[NKT cell-mediated immunotherapy for hematological malignancies]

Rinsho Ketsueki. 2007 Mar;48(3):188-99.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Combined Modality Therapy
  • Hematologic Neoplasms / immunology*
  • Hematologic Neoplasms / therapy*
  • Humans
  • Imatinib Mesylate
  • Immunity, Innate
  • Immunotherapy / methods*
  • Immunotherapy / trends
  • Killer Cells, Natural / immunology*
  • Lymphocyte Activation
  • Piperazines / therapeutic use
  • Pyrimidines / therapeutic use
  • T-Lymphocyte Subsets / immunology*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate